188 results match your criteria: "Ernest E. Moore Shock Trauma Center[Affiliation]"
J Trauma Acute Care Surg
December 2020
From the Department of Surgery (J.R.C., P.H.), University of Colorado-Denver, Aurora; Department of Surgery (K.L., R.A.L., E.E.M., F.P.), Ernest E Moore Shock Trauma Center at Denver Health; and Department of Internal Medicine (I.S.D.), Denver Health Medical Center, Denver, Colorado.
Introduction: Surgical stabilization of rib fractures (SSRF) remains a relatively controversial operation, which is often deferred because of concern about expense. The objective of this study was to determine the charges for SSRF versus medical management during index admission for rib fractures. We hypothesize that SSRF is associated with increased charge as compared with medical management.
View Article and Find Full Text PDFRes Pract Thromb Haemost
August 2020
Background: The coronavirus disease 2019 (COVID-19) pandemic has caused a large surge of acute respiratory distress syndrome (ARDS). Prior phase I trials (non-COVID-19) demonstrated improvement in pulmonary function in patients ARDS using fibrinolytic therapy. A follow-up trial using the widely available tissue-type plasminogen activator (t-PA) alteplase is now needed to assess optimal dosing and safety in this critically ill patient population.
View Article and Find Full Text PDFBlood Coagul Fibrinolysis
December 2020
Departments of Biological Engineering and Biology, Center for Precision Cancer Medicine, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge.
: Trauma with hemorrhagic shock causes massive tissue plasminogen activator release, plasmin generation, and hyperfibrinolysis. Tranexamic acid (TXA) has recently been used to treat bleeding in trauma by preventing plasmin generation to limit fibrinolysis. Trauma patients also have increased complement activation that correlates with mortality and organ failure, but the source of activation is not clear, and plasmin has recently been shown to efficiently cleave C3 and C5 to their activated fragments.
View Article and Find Full Text PDFAnn Surg
August 2020
Department of Surgery, Ernest E Moore Shock Trauma Center at Denver Health, Denver, CO.
J Trauma Acute Care Surg
November 2020
From the Department of Surgery, Cedars-Sinai Medical Center (E.J.L.), Los Angeles, California; Dell Medical School, University of Texas at Austin (C.V.R.B.), Austin, Texas; Ernest E. Moore Shock Trauma Center (E.E.M.), Denver, Colorado; MedStar Hospital Center (J.A.S.), Washington, District of Columbia; Scripps Mercy Hospital (K.P., M.J.M.), San Diego, California; Morsani College of Medicine (D.J.C.), Tampa, Florida; University of Pittsburgh (J.L.S.), Pittsburgh, Pennsylvania; Inova Trauma Center (A.G.R.), Falls Church, Virginia; Children's Hospital (N.G.R.), Cincinnati, Ohio; Oregon Health and Science University (K.J.B.), Portland, Oregon; University of Maryland School of Medicine (R.K.), Baltimore, Maryland; and Keck School of Medicine (K.I.), Los Angeles, California.
J Trauma Acute Care Surg
July 2020
From the Department of Surgery (J.R.C., E.E.M., M.J.C., J.M.S.), University of Colorado-Denver; Department of Surgery (E.E.M., M.J.C.), Ernest E Moore Shock Trauma Center at Denver Health, Denver, Colorado; Department of Emergency Medicine (K.F., N.D.G.), Department of Pharmacology (G.W.H.), University of Vermont Medical Center, Burlington, Vermont; and Department of Biochemistry and Molecular Genetics (K.H.), University of Colorado School of Medicine, Aurora, Colorado.
Background: While tissue injury provokes fibrinolysis shutdown in trauma, the mechanism remains elusive. Cellular death causes release of structural proteins, including actin and myosin, which may interact with clot formation and structure. We hypothesized that tissue injury is associated with high circulating actin and that actin produces a hypercoagulable profile with decreased fibrinolysis in vitro.
View Article and Find Full Text PDFRes Pract Thromb Haemost
May 2020
The coronavirus disease 2019 (COVID-19) pandemic has caused respiratory failure and associated mortality in numbers that have overwhelmed global health systems. Thrombotic coagulopathy is present in nearly three quarters of patients with COVID-19 admitted to the intensive care unit, and both the clinical picture and pathologic findings are consistent with microvascular occlusive phenomena being a major contributor to their unique form of respiratory failure. Numerous studies are ongoing focusing on anticytokine therapies, antibiotics, and antiviral agents, but none to date have focused on treating the underlying thrombotic coagulopathy in an effort to improve respiratory failure in COVID-19.
View Article and Find Full Text PDFMedian arcuate ligament syndrome (MALS) is an often discounted and vexing condition that may go unnoticed in a population of patients with complex comorbid conditions or those with poor psychiatric health. We report a unique case of a patient with anorexia nervosa in whom the successful operation for MALS was briefly complicated by a postoperative conversion disorder.
View Article and Find Full Text PDFJ Trauma Acute Care Surg
September 2020
From the Division of Acute Care Surgery (C.D.B., R.J., M.B.Y.), Trauma and Surgical Critical Care, Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston; Departments of Biological Engineering and Biology (C.D.B., M.B.Y.), Koch Institute for Integrative Cancer Research, Center for Precision Cancer Medicine, Massachusetts Institute of Technology, Cambridge; Department of Anesthesia (A.O.-G., A.M.I., M.L.K., D.S.T., S.S.), Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts; Division of Trauma and Surgical Critical Care (E.C., S.H.R., M.U.), Department of Surgery, Jacobi Medical Center, Albert Einstein College of Medicine, Bronx, New York; Division of Pulmonary and Critical Care (A.H.M.), Department of Medicine, St. Elizabeth's Medical Center, Tufts University School of Medicine, Boston, Massachusetts; Department of Surgery (M.J.M.), Scripps Mercy Hospital, San Diego, California; Department of Emergency Medicine (A.M.I.), Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts; Department of Surgery (H.B.M., E.E.M.), University of Colorado Denver, Aurora; Department of Surgery (E.E.M.), Ernest E Moore Shock Trauma Center at Denver Health, Denver, Colorado; Division of Pulmonary, Critical Care and Sleep Medicine (E.N.B.-K.), Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
The coronavirus disease 2019 (COVID-19) pandemic has led to unprecedented stresses on modern medical systems, overwhelming the resource infrastructure in numerous countries while presenting a unique series of pathophysiologic clinical findings. Thrombotic coagulopathy is common in critically ill patients suffering from COVID-19, with associated high rates of respiratory failure requiring prolonged periods of mechanical ventilation. Here, we report a case series of five patients suffering from profound, medically refractory COVID-19-associated respiratory failure who were treated with fibrinolytic therapy using tissue plasminogen activator (tPA; alteplase).
View Article and Find Full Text PDFJ Am Coll Surg
August 2020
Departments of Surgery.
Background: COVID-19 predisposes patients to a prothrombotic state with demonstrated microvascular involvement. The degree of hypercoagulability appears to correlate with outcomes; however, optimal criteria to assess for the highest-risk patients for thrombotic events remain unclear; we hypothesized that deranged thromboelastography measurements of coagulation would correlate with thromboembolic events.
Study Design: Patients admitted to an ICU with COVID-19 diagnoses who had thromboelastography analyses performed were studied.
ANZ J Surg
April 2020
Department of Surgery, University of Colorado-Anschutz Medical Campus, Aurora, Colorado, USA.
J Trauma Acute Care Surg
May 2020
From the School of Medicine, Department of Surgery, University of Colorado Anschutz Medical Campus (H.B.M., E.E.M., M.J.C., M.P.C., A.S.), Aurora, CO; University of Colorado Anschutz Medical Campus, School of Public Health, Department of Health Systems, Management and Policy (A.S.); Aurora, Colorado; University of Pittsburgh (M.T.T., J.L.S., F.X.G., J.B.B., M.N., B.Z.), Pittsburgh, Pennsylvania; Ernest E. Moore Shock Trauma Center at Denver Health (E.E.M., M.J.C.), Denver, Colorado; and Combat Casualty Care Research Program (A.E.P.), US Army Medical Research Materiel Command, Fort Detrick, Maryland.
Background: Randomized clinical trials (RCTs) support the use of prehospital plasma in traumatic hemorrhagic shock, especially in long transports. The citrate added to plasma binds with calcium, yet most prehospital trauma protocols have no guidelines for calcium replacement. We reviewed the experience of two recent prehospital plasma RCTs regarding admission ionized-calcium (i-Ca) blood levels and its impact on survival.
View Article and Find Full Text PDFWorld J Emerg Surg
April 2020
Koch Institute for Integrative Cancer Research, Center for Precision Cancer Medicine, Departments of Biological Engineering and Biology, Massachusetts Institute of Technology, Cambridge, MA, USA.
Background: COVID-19 threatens to quickly overwhelm our existing critical care infrastructure in the USA. Systemic tissue plasminogen activator (tPA) has been previously demonstrated to improve PaO/FiO (mmHg) when given to critically ill patients with acute respiratory distress syndrome (ARDS). It is unclear to what extent tPA may impact population-based survival during the current US COVID-19 pandemic.
View Article and Find Full Text PDFJ Thromb Haemost
August 2020
Department of Surgery, University of Colorado Denver, Aurora, CO, USA.
J Trauma Acute Care Surg
June 2020
From the Department of Surgery (H.B.M., E.E.M., R.C.M.), University of Colorado Denver, Denver, Colorado; Koch Institute for Integrative Cancer Research, Center for Precision Cancer Medicine, Departments of Biological Engineering and Biology (C.D.B., M.B.Y.), Massachusetts Institute of Technology, Cambridge; Division of Acute Care Surgery, Trauma and Surgical Critical Care, Department of Surgery (C.D.B., M.B.Y.), Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts; Department of Surgery (E.E.M.), Ernest E Moore Shock Trauma Center at Denver Health; Department of Medicine (P.K.M.), University of Colorado Denver, Denver, Colorado; Department of Anesthesia, Critical Care and Pain Medicine (D.S.T.), Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts; and Department of Surgery (F.A.M.), University of Florida, Gainesville, Florida.
World J Emerg Surg
April 2020
Emergency and Trauma Surgery, Maggiore Hospital, Parma, Italy.
Since December 2019, the world is potentially facing one of the most difficult infectious situations of the last decades. COVID-19 epidemic warrants consideration as a mass casualty incident (MCI) of the highest nature. An optimal MCI/disaster management should consider all four phases of the so-called disaster cycle: mitigation, planning, response, and recovery.
View Article and Find Full Text PDFJ Thromb Haemost
July 2020
Center for Precision Cancer Medicine, Departments of Biological Engineering and Biology, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
A prothrombotic coagulopathy is commonly found in critically ill COVID-19 patients with acute respiratory distress syndrome (ARDS). A unique feature of COVID-19 respiratory failure is a relatively preserved lung compliance and high Alveolar-arterial oxygen gradient, with pathology reports consistently demonstrating diffuse pulmonary microthrombi on autopsy, all consistent with a vascular occlusive etiology of respiratory failure rather than the more classic findings of low-compliance in ARDS. The COVID-19 pandemic is overwhelming the world's medical care capacity with unprecedented needs for mechanical ventilators and high rates of mortality once patients progress to needing mechanical ventilation, and in many environments including in parts of the United States the medical capacity is being exhausted.
View Article and Find Full Text PDFJ Thromb Haemost
March 2020
Beacon Medical Group Trauma and Surgical Research Services, South Bend, IN, USA.
World J Emerg Surg
February 2020
General, Emergency and Trauma Surgery Dept, Pisa University Hospital, Pisa, Italy.
Emergency surgeons have a crucial role in bridging the gap of skills resulting from the well-known general surgery fragmentation. The multi-specialist general surgery approach is still necessary to define proper diagnosis and therapy priorities in an emergency. Governments have to find effective organizational solutions to maintain emergency general surgery standards of care and to improve them further.
View Article and Find Full Text PDFWorld J Emerg Surg
February 2020
Department of Emergency and Trauma Surgery, University Hospital of Parma, 43100, Parma, Italy.
Background: Surgical site infections (SSI) represent a considerable burden for healthcare systems. They are largely preventable and multiple interventions have been proposed over past years in an attempt to prevent SSI. We aim to provide a position paper on Operative Room (OR) prevention of SSI in patients presenting with intra-abdominal infection to be considered a future addendum to the well-known World Society of Emergency Surgery (WSES) Guidelines on the management of intra-abdominal infections.
View Article and Find Full Text PDFJ Trauma Acute Care Surg
February 2020
From the Department of Surgery (N.D., Z.T.O., A.M.S., K.F.), University of Vermont, Burlington, Vermont; Ernest E Moore Shock Trauma Center at Denver Health (J.R.C., H.M., E.E.M.), University of Colorado Denver, Denver, Colorado; Department of Pharmacology (G.H., M.T.N.), University of Vermont, Burlington; and Department of Biochemistry (S.B.), University of Vermont, Colchester, Vermont.
Background: Both hyperfibrinolysis and fibrinolysis shutdown can occur after severe trauma. The subgroup of trauma patients with fibrinolysis shutdown resistant to tissue plasminogen activator (t-PA)-mediated fibrinolysis have increased mortality. Fibrin polymerization and structure may influence fibrinolysis subgroups in trauma, but fibrin architecture has not been characterized in acutely injured subjects.
View Article and Find Full Text PDFPlatelets
April 2021
Pittsburgh Trauma Research Center and Division of Trauma and Acute Care Surgery, University of Pittsburgh, Pittsburgh, PA, USA.
Platelets are damage sentinels of the intravascular compartment, initiating and coordinating the primary response to tissue injury. Severe trauma and hemorrhage induce profound alterations in platelet behavior. During the acute post-injury phase, platelets develop a state of impaired agonist responsiveness independent of platelet count, associated with systemic coagulopathy and mortality risk.
View Article and Find Full Text PDFJ Am Coll Surg
March 2020
Department of Surgery, University of Colorado-Denver, Aurora, CO.
Background: Hypertonic saline (23.4%, HTS) bolus administration is common practice for refractory intracranial hypertension, but its effects on coagulation are unknown. We hypothesize that 23.
View Article and Find Full Text PDF